Desensitization to trimethoprim/sulfamethoxazole in HIV-infected patients

The Journal of Allergy and Clinical Immunology

Volumn 93, Issue 6, 1994, Pages 1001-1005

  Absar, Noman ^a   Daneshvar, Hafez ^a   Beall, Gildon ^a  

^a NONE

Author keywords

AIDS; desensitization; drug reactions.; HIV 1 infection; trimethoprim sulfamethoxazole

Indexed keywords

COTRIMOXAZOLE; SULFAMETHOXAZOLE; TRIMETHOPRIM;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ANTIBIOTIC PROPHYLAXIS; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; DESENSITIZATION; DRUG HYPERSENSITIVITY; DRUG MIXTURE; FOLLOW UP; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; PNEUMOCYSTIS PNEUMONIA; PRIORITY JOURNAL; RASH;

ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; DESENSITIZATION, IMMUNOLOGIC; DRUG HYPERSENSITIVITY; HUMAN; MALE; MIDDLE AGE; PNEUMONIA, PNEUMOCYSTIS CARINII; SUPPORT, U.S. GOV'T, P.H.S.; TRIMETHOPRIM-SULFAMETHOXAZOLE COMBINATION;

EID: 0028365455     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-6749(94)70048-6     Document Type: Article

References (25)

1. Pneumocystis carinii pneumonia in the United States: epidemiologic, diagnostic, and clinical features
2. Guidelines for prophylaxis against Pneumocystis carinii pneumonia for persons infected with human immunodeficiency virus
3. NHLBI workshop summary: pulmonary complications of the acquired immunodeficiency syndrome: an update [Report of the second National Heart, Lung, and Blood Institute workshop]
4. Pulmonary complications of the acquired immunodeficiency syndrome [Report of a National Heart, Lung, and Blood Institute workshop]
5. Safety and efficacy of sulfamethoxazole and trimethoprim chemoprophylaxis for Pneumocystis carinii pneumonia in AIDS
6. Aerosolized pentamidine for prophylaxis against Pneumocystis carinii pneunomia: the San Francisco Community Prophylaxis Trial
7. A controlled trial of trimethoprim-sulfamethoxazole or aerosolized pentamidine for secondary prophylaxis of Pneumocystis carinii pneumonia in patients with the acquired immunodeficiency syndrome
8. A comparison of the effectiveness of three regimens in the prevention of Pneumocystis carinii pneumonia in human immunodeficiency virus–infected patients
9. Cost and benefit of secondary prophylaxis for Pneumocystis carinii pneumonia
10. Successful chemoprophylaxis for Pneumocystis carinii pneumonitis
11. Adverse reactions to trimethoprim-sulfamethoxazole in hospitalized patients
12. Complications of co-trimoxazole in treatment of AIDS-associated Pneumocystis carinii pneumonia in homosexual men
13. Cutaneous reaction to trimethoprim-sulfamethoxazole in patients with AIDS and Kaposi sarcoma [Letter]
14. Desensitization of patients with inflammatory bowel disease to sulfasalazine
15. Trimethoprim-sulfamethoxazole desensitization in the acquired immunodeficiency syndrome [Letter]
16. Co-trimoxazole desensitization in bone marrow transplantation
17. Oral desensitization of trimethoprim sulfamethoxazole in a patient with AIDS
18. Desensitization to sulfonamides in patients with HIV infection
19. Anaphylactic shock induced by oral desensitization to trimethoprim/sulfamethoxazole (TMP/SMZ)
20. Desensitization to trimethoprim sulfamethoxazole in patients with acquired immune deficiency syndrome and Pneumocystis carinii pneumonia
21. Detection of human IgE to sulfamethoxazole by skin testing with sulfamethoxazole-poly-L-tyrosine
22. Synthesis and in vitro toxicity of hydroxylamine metabolites of sulfonamides
23. Differences in metabolism of sulfonamides predisposing to idiosyncratic toxicity
24. Diagnosis of sulfonamide hypersensitivity reactions by in-vitro “rechallenge” with hydroxylamine metabolites